Keyphrases
Naltrexone
100%
CD4+
100%
Antiviral Drugs
100%
Lymphocyte Culture
100%
Anti-human Immunodeficiency virus-1 Activity
100%
Human Immunodeficiency Virus Type 1 (HIV-1)
55%
Opioid Receptors
22%
Indinavir
22%
Human Immunodeficiency virus-1 Infection
22%
Antiviral Activity
11%
Clinical Trials
11%
T Cells
11%
Adjunctive Therapy
11%
Alcohol Dependence
11%
Treatment Strategy
11%
Tropics
11%
Opioid Antagonist
11%
Safety Profile
11%
In Vitro Study
11%
Primary Cells
11%
Cell Targeting
11%
Potentiation
11%
In Vitro Activity
11%
Supernatant
11%
Zidovudine
11%
CD4+ T Lymphocytes
11%
Selective Antagonist
11%
Infected Patients
11%
Non-selective
11%
Synergistic Activity
11%
P24 Antigen
11%
Control Culture
11%
Drug-treated
11%
Antiviral Properties
11%
Opiate Dependent
11%
Antigen Levels
11%
CD4+ Lymphocytes
11%
Neuroscience
Naltrexone
100%
CD4
100%
Antiretroviral Drugs
100%
Human Immunodeficiency Virus
100%
Lymphocyte
100%
Opiate
33%
Antivirals
22%
Indinavir
22%
In Vitro
22%
T Cell
22%
Receptor
22%
Zidovudine
11%
Antigen P24
11%
Adjuvant Therapy
11%
Narcotic Antagonist
11%
Medicine and Dentistry
Anti-Human Immunodeficiency Virus
100%
Human Immunodeficiency Virus 1
100%
Lymphocyte Culture
100%
Naltrexone
100%
In Vitro
22%
Human Immunodeficiency Virus 1 Infection
22%
Antiviral Activity
22%
Indinavir
22%
Opioid Receptor
22%
T Cell
11%
Clinical Trial
11%
Opiate Antagonist
11%
Target Cell
11%
CD4+ T Lymphocyte
11%
Antigen P24
11%
Adjuvant Therapy
11%
Opiate
11%
Zidovudine
11%
Lymphocyte
11%